Related Experiment Video
Updated: Dec 11, 2025
Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
Published on: June 23, 2014
Oxidative Stress and Vascular Dysfunction in the Retina: Therapeutic Strategies
Yue Ruan1, Subao Jiang1, Aytan Musayeva1
1Department of Ophthalmology, University Medical Center, Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
Abstract:
Many retinal diseases, such as diabetic retinopathy, glaucoma, and age-related macular (AMD) degeneration, are associated with elevated reactive oxygen species (ROS) levels. ROS are important intracellular signaling molecules that regulate numerous physiological actions, including vascular reactivity and neuron function. However, excessive ROS formation has been linked to vascular endothelial dysfunction, neuron degeneration, and inflammation in the retina. ROS can directly modify cellular molecules and impair their function. Moreover, ROS can stimulate the production of inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) causing inflammation and cell death. However, there are various compounds with direct or indirect antioxidant activity that have been used to reduce ROS accumulation in animal models and humans. In this review, we report on the physiological and pathophysiological role of ROS in the retina with a special focus on the vascular system. Moreover, we present therapeutic approaches for individual retinal diseases targeting retinal signaling pathways involving ROS.
Insights
Reactive oxygen species (ROS) play a dual role in the retina, contributing to diseases like diabetic retinopathy and AMD. This review explores ROS
Area of Science:
- Ophthalmology and Molecular Biology: Focuses on the role of reactive oxygen species (ROS) in retinal physiology and pathology.
Background:
- Elevated ROS levels are implicated in major retinal diseases, including diabetic retinopathy, glaucoma, and age-related macular degeneration (AMD).
- ROS are critical signaling molecules but excessive production leads to vascular dysfunction, neurodegeneration, and inflammation via cytokine release (e.g., TNF-α, IL-6).
Purpose of the Study:
- To review the physiological and pathophysiological roles of ROS in the retina, particularly within the vascular system.
- To present therapeutic strategies targeting ROS-mediated signaling pathways for retinal diseases.
Main Methods:
- Literature review synthesizing existing research on ROS in retinal diseases.
- Analysis of the impact of ROS on retinal vascular and neuronal function.
- Examination of antioxidant compounds and therapeutic interventions.
Main Results:
- ROS are integral to retinal signaling but contribute to disease pathogenesis when overproduced.
- ROS-induced inflammation and cellular damage are key mechanisms in retinal diseases.
- Antioxidant strategies show promise in preclinical and clinical settings.
Conclusions:
- Understanding the complex role of ROS in the retina is crucial for developing effective treatments.
- Targeting ROS-dependent pathways offers a viable therapeutic avenue for various retinal conditions.
- Further research into antioxidant therapies can mitigate vision loss from retinal diseases.
